US Stock MarketDetailed Quotes

SLS Sellas Life Sciences

Watchlist

1.355
+0.065+5.04%

Close May 10 16:00 ET

1.340
-0.015-1.11%

Post 19:56 ET

78.26MMarket Cap-1011P/E (TTM)

Sellas Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-31.92%-31.41M

6.35%-4.83M

-19.94%-6.89M

-31.33%-7.57M

-69.61%-12.13M

8.50%-23.81M

-3.54%-5.15M

2.25%-5.75M

-17.62%-5.76M

30.37%-7.15M

Net income from continuing operations

9.59%-37.34M

10.80%-8.14M

-31.97%-9.27M

-5.06%-8.84M

33.73%-11.1M

-99.53%-41.3M

-38.24%-9.12M

0.89%-7.02M

-82.40%-8.41M

-596.80%-16.74M

Operating gains losses

88.89%-4K

--0

95.83%-2K

-118.18%-2K

-140.00%-36K

106.82%3K

93.33%-2K

-271.43%-48K

-64.52%11K

Other non cash items

-95.13%495K

372.34%128K

-37.76%122K

578.79%158K

-99.13%87K

344.02%10.16M

98.97%-47K

40.00%196K

-124.63%-33K

7,686.82%10.05M

Change In working capital

-40.70%3.35M

-24.70%2.69M

172.73%1.71M

-73.56%604K

-97.73%-1.66M

174.08%5.64M

636.98%3.57M

-23.72%627K

421.24%2.28M

89.81%-837K

-Change in receivables

----

--0

----

-77.30%-1M

-Change in prepaid assets

-90.98%113K

-7.22%694K

11.93%544K

-44.16%349K

-143.23%-1.47M

206.73%1.25M

-25.72%748K

295.18%486K

-16.78%625K

77.41%-606K

-Change in payables and accrued expense

-22.82%3.75M

-27.90%2.12M

267.90%1.3M

-43.61%419K

-110.76%-88K

372.06%4.86M

966.47%2.95M

-67.13%352K

132.96%743K

411.03%818K

-Change in other current liabilities

-9.98%-518K

-3.94%-132K

38.86%-129K

-95.24%-164K

-89.80%-93K

-157.38%-471K

30.60%-127K

---211K

---84K

---49K

Cash from discontinued investing activities

Operating cash flow

-31.92%-31.41M

6.35%-4.83M

-19.94%-6.89M

-31.33%-7.57M

-69.61%-12.13M

8.50%-23.81M

-3.54%-5.15M

2.25%-5.75M

-17.62%-5.76M

30.37%-7.15M

Investing cash flow

Cash flow from continuing investing activities

-22.22%-5.5M

-3M

-4.5M

Net intangibles purchase and sale

-22.22%-5.5M

--0

---3M

----

---4.5M

--0

----

Cash from discontinued investing activities

Investing cash flow

-22.22%-5.5M

--0

---3M

----

---4.5M

--0

----

Financing cash flow

Cash flow from continuing financing activities

-7.33%22.32M

264.48%3.39M

-49.53%54K

-100.13%-29K

40,121.28%18.9M

99.43%24.08M

1,758.00%929K

-95.23%107K

239.07%23M

-98.43%47K

Net common stock issuance

-7.37%22.23M

266.31%3.4M

--0

-100.13%-29K

--18.85M

166.45%23.99M

--929K

-96.92%69K

--23M

--0

Proceeds from stock option exercised by employees

42.35%121K

--14K

42.11%54K

--0

12.77%53K

-97.23%85K

--0

1,800.00%38K

--0

-98.43%47K

Net other financing activities

---31K

----

Cash from discontinued financing activities

Financing cash flow

-7.33%22.32M

264.48%3.39M

-49.53%54K

-100.13%-29K

40,121.28%18.9M

99.43%24.08M

1,758.00%929K

-95.23%107K

239.07%23M

-98.43%47K

Net cash flow

Beginning cash position

-19.72%17.23M

-81.03%4.07M

-48.66%13.91M

67.24%24M

-19.72%17.23M

-39.40%21.46M

-18.70%21.45M

-9.76%27.09M

-48.99%14.35M

-39.40%21.46M

Current changes in cash

-245.04%-14.6M

65.92%-1.44M

-74.46%-9.84M

-179.27%-10.1M

195.41%6.78M

69.67%-4.23M

14.27%-4.22M

-55.09%-5.64M

575.96%12.74M

2.28%-7.1M

End cash Position

-84.73%2.63M

-81.03%4.07M

-48.66%13.91M

67.24%24M

-19.72%17.23M

-18.70%21.45M

-9.76%27.09M

-48.99%14.35M

Free cash flow

-30.38%-36.91M

6.35%-4.83M

-72.15%-9.89M

1.90%-10.07M

-69.61%-12.13M

-8.79%-28.31M

-3.54%-5.15M

2.25%-5.75M

-109.49%-10.26M

30.37%-7.15M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-31.92%-31.41M	6.35%-4.83M	-19.94%-6.89M	-31.33%-7.57M	-69.61%-12.13M	8.50%-23.81M	-3.54%-5.15M	2.25%-5.75M	-17.62%-5.76M	30.37%-7.15M
Net income from continuing operations	9.59%-37.34M	10.80%-8.14M	-31.97%-9.27M	-5.06%-8.84M	33.73%-11.1M	-99.53%-41.3M	-38.24%-9.12M	0.89%-7.02M	-82.40%-8.41M	-596.80%-16.74M
Operating gains losses	88.89%-4K	--0	--0	95.83%-2K	-118.18%-2K	-140.00%-36K	106.82%3K	93.33%-2K	-271.43%-48K	-64.52%11K
Other non cash items	-95.13%495K	372.34%128K	-37.76%122K	578.79%158K	-99.13%87K	344.02%10.16M	98.97%-47K	40.00%196K	-124.63%-33K	7,686.82%10.05M
Change In working capital	-40.70%3.35M	-24.70%2.69M	172.73%1.71M	-73.56%604K	-97.73%-1.66M	174.08%5.64M	636.98%3.57M	-23.72%627K	421.24%2.28M	89.81%-837K
-Change in receivables	----	----	----	----	--0	----	----	----	----	-77.30%-1M
-Change in prepaid assets	-90.98%113K	-7.22%694K	11.93%544K	-44.16%349K	-143.23%-1.47M	206.73%1.25M	-25.72%748K	295.18%486K	-16.78%625K	77.41%-606K
-Change in payables and accrued expense	-22.82%3.75M	-27.90%2.12M	267.90%1.3M	-43.61%419K	-110.76%-88K	372.06%4.86M	966.47%2.95M	-67.13%352K	132.96%743K	411.03%818K
-Change in other current liabilities	-9.98%-518K	-3.94%-132K	38.86%-129K	-95.24%-164K	-89.80%-93K	-157.38%-471K	30.60%-127K	---211K	---84K	---49K
Cash from discontinued investing activities
Operating cash flow	-31.92%-31.41M	6.35%-4.83M	-19.94%-6.89M	-31.33%-7.57M	-69.61%-12.13M	8.50%-23.81M	-3.54%-5.15M	2.25%-5.75M	-17.62%-5.76M	30.37%-7.15M
Investing cash flow
Cash flow from continuing investing activities	-22.22%-5.5M	0	-3M			-4.5M	0	0
Net intangibles purchase and sale	-22.22%-5.5M	--0	---3M	----	----	---4.5M	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-22.22%-5.5M	--0	---3M	----	----	---4.5M	--0	--0	----	----
Financing cash flow
Cash flow from continuing financing activities	-7.33%22.32M	264.48%3.39M	-49.53%54K	-100.13%-29K	40,121.28%18.9M	99.43%24.08M	1,758.00%929K	-95.23%107K	239.07%23M	-98.43%47K
Net common stock issuance	-7.37%22.23M	266.31%3.4M	--0	-100.13%-29K	--18.85M	166.45%23.99M	--929K	-96.92%69K	--23M	--0
Proceeds from stock option exercised by employees	42.35%121K	--14K	42.11%54K	--0	12.77%53K	-97.23%85K	--0	1,800.00%38K	--0	-98.43%47K
Net other financing activities	---31K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-7.33%22.32M	264.48%3.39M	-49.53%54K	-100.13%-29K	40,121.28%18.9M	99.43%24.08M	1,758.00%929K	-95.23%107K	239.07%23M	-98.43%47K
Net cash flow
Beginning cash position	-19.72%17.23M	-81.03%4.07M	-48.66%13.91M	67.24%24M	-19.72%17.23M	-39.40%21.46M	-18.70%21.45M	-9.76%27.09M	-48.99%14.35M	-39.40%21.46M
Current changes in cash	-245.04%-14.6M	65.92%-1.44M	-74.46%-9.84M	-179.27%-10.1M	195.41%6.78M	69.67%-4.23M	14.27%-4.22M	-55.09%-5.64M	575.96%12.74M	2.28%-7.1M
End cash Position	-84.73%2.63M	-84.73%2.63M	-81.03%4.07M	-48.66%13.91M	67.24%24M	-19.72%17.23M	-19.72%17.23M	-18.70%21.45M	-9.76%27.09M	-48.99%14.35M
Free cash flow	-30.38%-36.91M	6.35%-4.83M	-72.15%-9.89M	1.90%-10.07M	-69.61%-12.13M	-8.79%-28.31M	-3.54%-5.15M	2.25%-5.75M	-109.49%-10.26M	30.37%-7.15M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall